Delivery Order SPE2DB20D1050-SPE2DB25FH80Y
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count units) valued at $7,179.96. This firm fixed-price, non-set-aside contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award represents a single fulfillment action under a larger contracting vehicle...
- The Defense Logistics Agency awarded a $57,659.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90-count bottles of Gemtesa 75 mg tablets, with an ultimate completion date of July 25, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's broader supply relationship with the federal government. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) with a ceiling value of $6,303.55. The contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, utilizing firm fixed price pricing with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award...
- The Defense Logistics Agency awarded a delivery order valued at $13,881.40 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90 count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a $3,493.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Gemtesa 75 mg, with an ultimate completion date of August 4, 2025. This non-competitive delivery order, issued on August 1, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order valued at $1,279.87 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (30-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and healthcare systems. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $38,627.45 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count) on July 22, 2025, with completion expected by July 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $14,664.71 delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, will...
- The Defense Logistics Agency awarded a delivery order valued at $1,734.04 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count package) on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) under a firm fixed price contract valued at $2,679.48. This delivery order, with an ultimate completion date of July 22, 2025, represents a small-value pharmaceutical procurement with no set-aside designation, indicating the award was made through competitive procedures. The contract will be performed at AmerisourceBergen's corporate...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH80YDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count) with a ceiling value of $1,722.87. This firm fixed-price delivery order, awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a non-competitive award under an existing contract vehicle. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary distribution hub for federal medical procurement operations. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle functions as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The Gemtesa order exemplifies the company's role as a critical vendor in the federal medical supply chain, fulfilling pharmaceutical procurement needs across the Defense Health Agency and other military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/30/25 |